Physician

Alberto Omar Chavez Velazquez, MD

According to 2025 Medicare claims, Alberto Velazquez, MD (NPI: 1679865414) practices endocrinology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is COMMUNITY MEDICINE ASSOCIATES (NPI: 1245313329; TIN: 742932237) and primary practice location at 78207-5209.

Velazquez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 92 traditional Medicare patients, billed 312 HCPCS/CPT codes, and received $14,466 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,745 prescription claims across 471 beneficiaries totaling $4,325,543 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 164 claims. Open Payments data shows 4 records totaling $353. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $203,510 to $4,325,543. For DME billing, reported payments moved sharply higher in recent years, from $1,748 to $40,039.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	56	89	$6,317
2016	86	226	$13,485
2017	95	250	$13,646
2018	96	232	$13,040
2019	123	290	$16,605
2020	117	286	$12,435
2021	121	239	$13,920
2022	109	231	$13,747
2023	98	200	$12,925
2024	92	312	$14,466

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	92	518	$203,510
2016	161	1,459	$631,111
2017	196	2,207	$1,003,797
2018	225	2,528	$1,234,166
2019	273	3,056	$1,654,851
2020	318	3,465	$1,885,293
2021	379	4,098	$2,463,630
2022	429	5,185	$3,683,760
2023	478	6,292	$4,746,362
2024	471	6,745	$4,325,543

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	30	65	$1,013
2017	38	82	$1,258
2018	56	114	$2,071
2019	58	136	$2,615
2020	53	122	$4,955
2021	29	98	$8,856
2022	33	146	$15,826
2023	32	179	$23,900
2024	34	164	$31,618

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	13	13	$76
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	81	166	$68
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	67	112	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	434	21,335	$759,996
Ozempic	Semaglutide	277	16,069	$505,100
Trulicity	Dulaglutide	222	12,944	$416,378
Farxiga	Dapagliflozin Propanediol	270	20,925	$374,276
Jardiance	Empagliflozin	236	19,326	$360,648

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	22	101	$30,561
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	34	$977
A4259	Lancets, per box of 100	N	N/R	17	$45
A4256	Normal, low and high calibrator solution / chips	N	N/R	12	$35

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$353	Esperion Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alberto Omar Chavez Velazquez, MD?

Tedicare shows public-source Medicare data for Alberto Omar Chavez Velazquez, MD (NPI 1679865414), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto Omar Chavez Velazquez, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alberto Omar Chavez Velazquez, MD?

Alberto Omar Chavez Velazquez, MD is linked to COMMUNITY MEDICINE ASSOCIATES (billing NPI 1245313329) in the available physician profile data.

Does Alberto Omar Chavez Velazquez, MD have Open Payments data?

Alberto Omar Chavez Velazquez, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.